Soleno Therapeutics, Inc. (SLNO) Tops Q2 EPS by 2c
Get Alerts SLNO Hot Sheet
Join SI Premium – FREE
Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q2 EPS of ($0.81), $0.02 better than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Euroseas Ltd. (ESEA) Tops Q2 EPS by 61c
- Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share